PBS Documentary “The Gene Doctors” Brings Rare Treatments to the Public Eye
source: pixabay.com

PBS Documentary “The Gene Doctors” Brings Rare Treatments to the Public Eye

Earlier this month, PBS released the "The Gene Doctors." The hour-long documentary follows the recent emergence of gene therapy as a novel method of treating rare diseases. The film discusses…

Continue Reading PBS Documentary “The Gene Doctors” Brings Rare Treatments to the Public Eye
Is Zika a Risk Factor For Guillain-Barre Syndrome? New Research Sheds Light
Source: pixabay.com

Is Zika a Risk Factor For Guillain-Barre Syndrome? New Research Sheds Light

You may have heard the buzz during the Zika outbreak in 2016. Many professionals suspected a relationship between the Zika virus and Guillain Barre Syndrome (GBS). Guillain Barre Syndrome is…

Continue Reading Is Zika a Risk Factor For Guillain-Barre Syndrome? New Research Sheds Light
19 Tips from an LGS Family: Traveling When Your Child Has Special Needs – Part 1
Source: Pixabay

19 Tips from an LGS Family: Traveling When Your Child Has Special Needs – Part 1

Traveling is certainly possible and can be more relaxing with some pre-planning and organization.  Some of these ideas may not be applicable to you and your family.  I have compiled…

Continue Reading 19 Tips from an LGS Family: Traveling When Your Child Has Special Needs – Part 1
How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research
Source: Pixabay

How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research

Rare disease research can feel like an uphill battle. First of all, rare diseases have a harder time receiving funding. After that, it takes months or even years to have…

Continue Reading How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research

Safer, More Efficient CRISPR Tech Offers Possible Duchenne Muscular Dystrophy Treatment

We've written about CRISPR technology before, and it's potential for treating sickle cell anemia. But in a latest study done at the University of California, Berkeley, sponsored by the NIH,…

Continue Reading Safer, More Efficient CRISPR Tech Offers Possible Duchenne Muscular Dystrophy Treatment